Skip to main content

Table 1 Characteristics of study population by gender and serum uric acid quartile

From: Hyperuricemia and the risk for subclinical coronary atherosclerosis - data from a prospective observational cohort study

  Women (n= 1,287) Men (n= 1,211)
  Quartile 1 Quartile 2 Quartile 3 Quartile 4 Quartile 1 Quartile 2 Quartile 3 Quartile 4
sUA range, μmol/L [mg/dL] 77-196 [1.3-3.3] 196-226 [3.3-3.8] 232-274 [3.9-4.6] 280-636 [4.7-10.7] 155-291 [2.6-4.9] 297-333 [5.0-5.6] 339-393 [5.7-6.6] 399-690 [6.7-11.6]
Age, years 40.1 (3.8) 40.1 (3.6) 40.3 (3.6) 40.5 (3.8) 40.1 (3.6) 39.8 (3.5) 40.4 (3.5) 40.4 (3.6)
African-American 43.5% 42.6% 46.5% 57.5% 42.7% 37.4% 42.5% 43.2%
Body mass index, kg/m2 24.8 (4.7) 27.2 (6.2) 29.6 (6.8) 33.1 (7.2) 26.1 (3.8) 27.4 (4) 28.1 (4.5) 30.1 (4.6)
Alcohol, mL/day 6.2 (10) 5.7 (11.8) 9 (32.7) 9.1 (22) 13.3 (35.4) 14.2 (25.1) 16.2 (24.4) 20.3 (35.1)
Smokers 36.6% 39.7% 38% 46.2% 35.3% 39.4% 39.3% 40.2%
Systolic BP, mm Hg 107 (12.5) 109.3 (14) 112.4 (15.3) 115.5 (16.3) 111.7 (11.2) 114.8 (13.5) 115.4 (12.9) 118.3 (14.7)
Diastolic BP, mm Hg 69.6 (10.1) 71.5 (10.2) 73.3 (10.9) 75.9 (12.6) 73.3 (9.2) 76.3 (11) 76.8 (10.2) 79.2 (12.1)
Serum fasting glucose, mmol/L [mg/dL] 4.45 (0.40) [80.2 (7.2)] 4.48 (0.43) [80.7 (7.7)] 4.5 (0.45) [81.1 (8.1)] 4.7 (0.53) [84.3 (9.5)] 4.7 (0.46) [84 (8.3)] 4.8 (0.53) [85.7 (9.6)] 4.8 (0.52) [86.4 (9.4)] 4.9 (0.54) [88.8 (9.7)]
Serum HDL-C, mmol/L [mg/dL] 1.54 (0.33) [59.7 (12.8)] 1.44 (0.35) [55.5 (13.5)] 1.45 (0.36) [56 (14.1)] 1.32 (0.37) [51 (14.4)] 1.24 (0.33) [48 (12.9)] 1.19 (0.32) [45.9 (12.4)] 1.14 (0.31) [43.9 (11.8)] 1.10 (0.33) [42.4 (12.6)]
Serum LDL-C, mmol/L [mg/dL] 2.72 (0.73) [105.1 (28.2)] 2.74 (0.74) [105.9 (28.7)] 2.80 (7.7) [108.4 (29.8)] 3.01 (0.79) [116.3 (30.6)] 2.87 (0.74) [110.9 (28.5)] 3.12 (0.81) [120.5 (31.5)] 3.19 (0.95) [123.5 (36.6)] 3.23 (0.92) [125 (35.7)]
Serum triglycerides, mmol/L [mg/dL] 0.78 (0.38) [68.8 (33.8)] 0.89 (0.44) [78.7 (39.1)] 0.95 (0.52) [84.5 (45.8)] 1.27 (0.80) [112.6 (70.7)] 1.01 (0.67) [89.8 (59.7)] 1.26 (0.76) [111.5 (67.4)] 1.52 (1.87) [135 (165.7)] 1.86 (1.76) [164.8 (156.1)]
Serum creatinine, μmol/L [mg/dL] 79.6 (8.8) [0.9 (0.1)] 79.6 (8.8) [0.9 (0.1)] 79.6 (8.8) [0.9 (0.1)] 79.6 (8.8) [0.9 (0.1)] 97.2 (8.8) [1.1 (0.1)] 97.2 (8.8) [1.1 (0.1)] 97.2 (17.7) [1.1 (0.2)] 97.2 (17.7) [1.1 (0.2)]
Waist circumference, cm 76.6 (10.1) 81.6 (12.1) 86.3 (13.1) 94 (14.1) 87.8 (9.5) 91.8 (9.6) 93.5 (11) 98.4 (10.9)
eGFR, abbreviated MDRD 87.2 (15.1) 85.6 (15.5) 83.9 (14.2) 82.7 (15.2) 89.9 (13.6) 88.3 (14.1) 87.1 (19.3) 85.6 (16.1)
Framingham risk score -4.8 (4.1) -3.7 (4.3) -3.3 (4.4) -1.4 (4.3) 1.1 (2.2) 1.8 (2.4) 2.3 (2.3) 2.7 (2.4)
C-reactive protein, mg/dL 1.5 (2.9) 1.5 (1.7) 1.6 (2.9) 1.8 (1.7) 1.7 (2.9) 1.8 (2.0) 2.0 (2.5) 2.1 (2.5)
  1. Data are presented as range, mean (standard deviation), or percentage. BP, blood pressure; eGFR, estimated glomerular filtration rate; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; MDRD, modification of diet in renal disease; sUA, serum uric acid.